$MNKD 4/A SEC Filings

Filed On	Filing
08 May 2026	Form 4/A: Castagna Michael, Director Holds 2,475,911 shares of Common Stock $0.01 Par Value
27 May 2025	Form 4/A: Blank Burkhard, EVP Chief Medical Officer Holds 480,754 shares of Common Stock $0.01 Par Value
28 Mar 2025	Form 4/A: Prentiss Christopher B, Chief Financial Officer Received 103,600 shares as a grant or award
03 Oct 2023	Form 4/A: Castagna Michael, Director Sold 10,000 shares ($40.8K)
07 Jul 2023	Form 4/A: Castagna Michael, Director Sold 4,414 shares ($18K) · Sold 5,586 shares ($22.4K)
30 May 2023	Form 4/A: Binder Steven B., Chief Financial Officer Gave up 281,267 shares to cover exercise price or tax ($1.35M)
24 Aug 2022	Form 4/A: Castagna Michael, Director Received 3,147 shares as a grant or award ($9.22K)
24 Aug 2022	Form 4/A: Binder Steven B., Chief Financial Officer Received 791 shares as a grant or award ($2.32K)
24 Aug 2022	Form 4/A: Tross Stuart A, Chief People & Workpl Officer Received 4,581 shares as a grant or award ($13.4K)
24 Aug 2022	Form 4/A: Tross Stuart A, Chief People & Workpl Officer Received 9,225 shares as a grant or award ($25K)
24 Aug 2022	Form 4/A: Galindo Alejandro, EVP Endocrine Business Unit Received 36,900 shares as a grant or award ($100K)
24 Aug 2022	Form 4/A: Binder Steven B., Chief Financial Officer Received 711 shares as a grant or award ($2.25K)
24 Aug 2022	Form 4/A: Castagna Michael, Director Received 27,675 shares as a grant or award ($75K)
24 Aug 2022	Form 4/A: Tross Stuart A, Chief People & Workpl Officer Received 2,254 shares as a grant or award ($7.15K)
24 Aug 2022	Form 4/A: Galindo Alejandro, EVP Endocrine Business Unit Received 5,000 shares as a grant or award ($14.7K)
24 Aug 2022	Form 4/A: Castagna Michael, Director Received 1,804 shares as a grant or award ($5.72K)
24 Aug 2022	Form 4/A: Galindo Alejandro, EVP Endocrine Business Unit Received 1,804 shares as a grant or award ($5.72K)
25 May 2022	Form 4/A: Galindo Alejandro, EVP Endocrine Business Unit Acquired 4,789 shares (Discretionary Transaction) ($15.3K)
09 Feb 2022	Form 4/A: Galindo Alejandro, Chief Commercial Officer Bought 1,804 shares ($5.72K)
09 Feb 2022	Form 4/A: Castagna Michael, Director Bought 1,804 shares ($5.72K)

Comments